Cargando…

Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer

BACKGROUND: Macrophage inhibitory cytokine-1(MIC-1) is a potential modulator of systemic inflammation and nutritional depletion, both of which are adverse prognostic factors in oesophago-gastric cancer (OGC). METHODS: Plasma MIC-1, systemic inflammation (defined as plasma C-reactive protein (CRP) of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skipworth, R J E, Deans, D A C, Tan, B H L, Sangster, K, Paterson-Brown, S, Brown, D A, Hunter, M, Breit, S N, Ross, J A, Fearon, K C H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837566/ https://www.ncbi.nlm.nih.gov/pubmed/20104227 http://dx.doi.org/10.1038/sj.bjc.6605532

Ejemplares similares

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience
por: Halliday, Brian P, et al.
Publicado: (2007)

The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
por: Wayman, J, et al.
Publicado: (2002)

Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer
por: Deans, D A C, et al.
Publicado: (2006)

Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
por: Högner, Anica, et al.
Publicado: (2021)

Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma
por: Suwaidan, Ali Abdulnabi, et al.
Publicado: (2022)

Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
por: De Silva, Nadeera, et al.
Publicado: (2015)

Re-organisation of oesophago-gastric cancer care in England: progress and remaining challenges
por: Palser, Thomas R, et al.
Publicado: (2009)

The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer
por: Deans, D A C, et al.
Publicado: (2009)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients
por: Eley, H L, et al.
Publicado: (2008)

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
por: Roy, A, et al.
Publicado: (2012)

Propofol Sedation for Oesophago-Gastro-Duodenoscopy
por: Watt, J. M., et al.
Publicado: (1999)

Modified Oesophago-Gastric Dissociation (M-OGD) — a technical modification
por: Coletta, Riccardo, et al.
Publicado: (2020)

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial
por: Lorenzen, Sylvie, et al.
Publicado: (2011)

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
por: Reynolds, JV, et al.
Publicado: (2017)

The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review
por: Patel, Nikhil Manish, et al.
Publicado: (2023)

Double stenting for malignant oesophago-respiratory fistula
por: Włodarczyk, Janusz, et al.
Publicado: (2016)

Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines
por: Stewart, G D, et al.
Publicado: (2008)

Feasibility of Implementation and the Impact of a Digital Prehabilitation Service in Patients Undergoing Treatment for Oesophago-Gastric Cancer
por: Moorthy, Krishna, et al.
Publicado: (2023)

Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer
por: Blencowe, N S, et al.
Publicado: (2013)

Machine Learning for Risk Prediction of Oesophago-Gastric Cancer in Primary Care: Comparison with Existing Risk-Assessment Tools
por: Briggs, Emma, et al.
Publicado: (2022)

Re-organisation of oesophago-gastric cancer services in England and Wales: a follow-up assessment of progress and remaining challenges
por: Groene, Oliver, et al.
Publicado: (2014)

Psychosocial functioning in individuals with advanced oesophago-gastric cancer: a mixed methods systematic review
por: Ghiglieri, Cara, et al.
Publicado: (2023)

Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012–2020
por: Pucher, Philip H, et al.
Publicado: (2023)

The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case–control study using electronic records
por: Stapley, S, et al.
Publicado: (2013)

A pooled analysis of molecularly targeted agents for treatment of metastatic oesophago-gastric cancer in elderly patients
por: Lv, Hui, et al.
Publicado: (2020)

ASO Author Reflections: Applications of Artificial Intelligence in Oesophago-Gastric Malignancies—Present Work and Future Directions
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Evaluating the care received by patients with oesophago-gastric (OG) cancer: the richer picture provided by linked datasets
por: Brand, Christian, et al.
Publicado: (2017)

Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy
por: Deans, D A C, et al.
Publicado: (2008)

Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
por: Deans, D A C, et al.
Publicado: (2006)

A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer—the ChemoFit study protocol
por: Chmelo, J., et al.
Publicado: (2020)

Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer – as measured by EORTC tools
por: Tomaszewski, Krzysztof A., et al.
Publicado: (2013)

The rare case of oesophago-pericardial fistula secondary to pulmonary tuberculosis
por: Sidhu, Kavina Kaur, et al.
Publicado: (2022)

The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis
por: Chan, David L., et al.
Publicado: (2017)

Research protocol for a diagnostic study of non-invasive exhaled breath analysis for the prediction of oesophago-gastric cancer
por: Markar, Sheraz R, et al.
Publicado: (2016)

Volume-outcome revisited: The effect of hospital and surgeon volumes on multiple outcome measures in oesophago-gastric cancer surgery
por: Fischer, Claudia, et al.
Publicado: (2017)

Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15
por: Tsai, Vicky W. W., et al.
Publicado: (2012)

Understanding Potentially Preventable Mortality Following Oesophago-Gastric Cancer Surgery: Analysis of a National Audit of Surgical Mortality
por: Liu, David S., et al.
Publicado: (2023)

First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-β Superfamily Cytokine, MIC-1/GDF15
por: Low, Jac Kee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2eqlkcdn3e100htljnhc37u9l1